For example, in androgen receptor overexpressing salivary duct carcinoma, there are pre-clinical studies showing AR-dependency in cultured salivary duct carcinoma cell lines [28,29] and phase 2 data for combined androgen blockade [30] which is being adopted as a standard of care. This evidence concerns the gene AR and salivary duct carcinoma.